無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙SALE
市場調査レポート

組織足場材料の世界市場:2018年〜2022年

Global Tissue Scaffolds Market 2018-2022

発行 TechNavio (Infiniti Research Ltd.) 商品コード 603610
出版日 ページ情報 英文 131 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.91円で換算しております。
Back to Top
組織足場材料の世界市場:2018年〜2022年 Global Tissue Scaffolds Market 2018-2022
出版日: 2018年02月06日 ページ情報: 英文 131 Pages
概要

組織足場材料について

組織足場材料は、細胞増殖および分化のための好ましい環境を提供する天然または合成の生体適合性材料からなる細胞増殖支持構造です。

Technavioのアナリストは、2018年から2022年の間に、世界の組織足場材料市場が12.14%のCAGRで成長すると予測しています。

当レポートでは、世界の組織足場材料市場について調査分析し、市場規模と成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 調査範囲

第3章 調査方法

第4章 市場状況

  • 市場のエコシステム
  • 市場特性
  • 市場セグメンテーション分析

第5章 市場規模

  • 市場の定義
  • 市場規模
  • 市場規模と予測

第6章 ファイブフォース分析

  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 新規参入の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市場状況

第7章 市場セグメンテーション:製品別

  • セグメンテーション:製品別
  • 比較:製品別
  • 天然組織足場材料
  • 合成組織足場材料
  • 市場機会:製品別

第8章 市場セグメンテーション:アプリケーション別

  • セグメンテーション:アプリケーション別
  • 比較:アプリケーション別
  • 筋骨格
  • 皮膚科
  • 心臓血管
  • その他

第9章 顧客情勢

第10章 地域情勢

  • 地理的セグメンテーション
  • 地域比較
  • 南北アメリカ
  • 欧州・中東・アフリカ地域
  • アジア太平洋地域
  • 主な先進国
  • 市場機会:地域別

第11章 意思決定の枠組み

第12章 成長要因と課題

  • 市場の成長要因
  • 市場の課題

第13章 市場動向

  • 拡大するM&Aと戦略的協業
  • 技術進歩の拡大

第14章 ベンダー情勢

  • 概要
  • 創造的破壊
  • 競合シナリオ

第15章 ベンダー分析

  • 対象ベンダー
  • ベンダーの分類
  • ベンダーの市場ポジショニング
  • Bioventus
  • Integra Lifesciences
  • MiMedx Group
  • Organogenesis
  • RTI Surgical
  • Smith & Nephew
  • 他の有力なベンダー

第16章 付録

  • 略語リスト
図表
  • Exhibit 01: Parent market
  • Exhibit 02: Global regenerative medicine market: Segmentation
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size
  • Exhibit 07: Validation techniques employed for market sizing 2017
  • Exhibit 08: Global tissue scaffolds market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 09: Global tissue scaffolds market - Year over year growth 2018-2022 (%)
  • Exhibit 10: Five forces analysis 2017
  • Exhibit 11: Five forces analysis 2022
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2017
  • Exhibit 18: Global tissue scaffolds market - Market share 2017-2022 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: Global natural tissue scaffolds market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 21: Global natural tissue scaffolds market - Year over year growth 2018-2022 (%)
  • Exhibit 22: Global synthetic tissue scaffolds market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 23: Global synthetic tissue scaffolds market - Year over year growth 2018-2022 (%)
  • Exhibit 24: Market opportunity by product
  • Exhibit 25: Tissue scaffold market by application - Market share 2017-2022 (%)
  • Exhibit 26: Customer landscape
  • Exhibit 27: Global tissue scaffolds market - Market share by region 2017-2022 (%)
  • Exhibit 28: Regional comparison
  • Exhibit 29: Tissue scaffolds market in Americas - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 30: Tissue scaffolds market in Americas - Year over year growth 2018-2022 (%)
  • Exhibit 31: Top two countries in Americas
  • Exhibit 32: Tissue scaffolds market in EMEA - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 33: Tissue scaffolds market in EMEA - Year over year growth 2018-2022 (%)
  • Exhibit 34: Top two countries in EMEA
  • Exhibit 35: Tissue scaffolds market in APAC - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 36: Tissue scaffolds market in APAC - Year over year growth 2018-2022 (%)
  • Exhibit 37: Top two countries in APAC
  • Exhibit 38: Key leading countries
  • Exhibit 39: Market opportunity by geography
  • Exhibit 40: Vendor landscape
  • Exhibit 41: Landscape disruption
  • Exhibit 42: Competitive structure analysis of global tissue scaffolds market 2017
  • Exhibit 43: Vendors covered
  • Exhibit 44: Vendor classification
  • Exhibit 45: Market positioning of vendors
  • Exhibit 46: Bioventus: Overview
  • Exhibit 47: Bioventus: Business segments
  • Exhibit 48: Bioventus: Organizational developments
  • Exhibit 49: Bioventus: Geographic focus
  • Exhibit 50: Bioventus: Segment focus
  • Exhibit 51: Bioventus: Key offerings
  • Exhibit 52: Bioventus: Key customers
  • Exhibit 53: Integra LifeSciences: Overview
  • Exhibit 54: Integra LifeSciences: Business segments
  • Exhibit 55: Integra LifeSciences: Organizational developments
  • Exhibit 56: Integra LifeSciences: Geographic focus
  • Exhibit 57: Integra LifeSciences: Segment focus
  • Exhibit 58: Integra LifeSciences: Key offerings
  • Exhibit 59: Integra LifeSciences: Key customers
  • Exhibit 60: MiMedx Group: Overview
  • Exhibit 61: MiMedx Group: Business segments
  • Exhibit 62: MiMedx Group: Organizational developments
  • Exhibit 63: MiMedx Group: Geographic focus
  • Exhibit 64: MidMedx Group: Segment focus
  • Exhibit 65: MidMedx Group: Key offerings
  • Exhibit 66: MiMedx Group: Key customers
  • Exhibit 67: Organogenesis: Overview
  • Exhibit 68: Organogenesis: Business segments
  • Exhibit 69: Organogenesis: Organizational developments
  • Exhibit 70: Organogenesis: Geographic focus
  • Exhibit 71: Organogenesis: Segment focus
  • Exhibit 72: Organogenesis: Key offerings
  • Exhibit 73: Organogenesis: Key customers
  • Exhibit 74: RTI Surgical: Overview
  • Exhibit 75: RTI Surgical: Business segments
  • Exhibit 76: RTI Surgical: Organizational developments
  • Exhibit 77: RTI Surgical: Geographic focus
  • Exhibit 78: RTI Surgical: Segment focus
  • Exhibit 79: RTI Surgical: Key offerings
  • Exhibit 80: RTI Surgical: Key customers
  • Exhibit 81: Smith & Nephew: Overview
  • Exhibit 82: Smith & Nephew: Business segments
  • Exhibit 83: Smith & Nephew: Organizational developments
  • Exhibit 84: Smith & Nephew: Geographic focus
  • Exhibit 85: Smith & Nephew: Segment focus
  • Exhibit 86: Smith & Nephew: Key offerings
  • Exhibit 87: Smith & Nephew: Key customers
目次
Product Code: IRTNTR20852

About Tissue Scaffolds

Tissue scaffolds are cell growth supporting structures composed of natural or synthetic biocompatible materials that provide a favorable environment for cell proliferation and differentiation.

Technavio's analysts forecast the global tissue scaffolds market to grow at a CAGR of 12.14% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global tissue scaffolds market for 2018-2022. To calculate the market size, the report considers the revenue generated from the tissue scaffolds.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Tissue Scaffolds Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Bioventus
  • Integra Lifesciences
  • MiMedx Group
  • Organogenesis
  • RTI Surgical
  • Smith & Nephew

Market driver

  • Growing occurrence of chronic and acute wounds
  • For a full, detailed list, view our report

Market challenge

  • Limitations of tissue scaffolds
  • For a full, detailed list, view our report

Market trend

  • Increasing technological advances
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing
  • Market size and forecast

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY PRODUCT

  • Segmentation by product
  • Comparison by product
  • Natural tissue scaffolds
  • Synthetic tissue scaffolds
  • Market opportunity by product

PART 08: MARKET SEGMENTATION BY APPLICATION

  • Segmentation by application
  • Comparison by application
  • Musculoskeletal
  • Dermatological
  • Cardiovascular
  • Others

PART 09: CUSTOMER LANDSCAPE

PART 10: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Tissue scaffolds market in Americas
  • Tissue scaffolds market in EMEA
  • Tissue scaffolds market in APAC
  • Key leading countries
  • Market opportunity by region

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 13: MARKET TRENDS

  • Growing M&A and strategic collaborations
  • Increasing technological advances

PART 14: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 15: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Bioventus
  • Integra Lifesciences
  • MiMedx Group
  • Organogenesis
  • RTI Surgical
  • Smith & Nephew
  • Other prominent vendors

PART 16: APPENDIX

  • List of abbreviations
Back to Top